Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3KJS

Crystal Structure of T. cruzi DHFR-TS with 3 high affinity DHFR inhibitors: DQ1 inhibitor complex

3KJS の概要
エントリーDOI10.2210/pdb3kjs/pdb
関連するPDBエントリー2H2Q 3CL9 3CLB 3KJU 3KJW
分子名称Dihydrofolate reductase-thymidylate synthase, ethyl 4-(5-{[(2,4-diaminoquinazolin-6-yl)methyl]amino}-2-methoxyphenoxy)butanoate, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, ... (6 entities in total)
機能のキーワードoxidoreductase, transferase
由来する生物種Trypanosoma cruzi
タンパク質・核酸の鎖数4
化学式量合計241867.23
構造登録者
Schormann, N.,Senkovich, O.,Chattopadhyay, D. (登録日: 2009-11-03, 公開日: 2010-06-09, 最終更新日: 2023-09-06)
主引用文献Schormann, N.,Velu, S.E.,Murugesan, S.,Senkovich, O.,Walker, K.,Chenna, B.C.,Shinkre, B.,Desai, A.,Chattopadhyay, D.
Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase.
Bioorg.Med.Chem., 18:4056-4066, 2010
Cited by
PubMed Abstract: Dihydrofolate reductase (DHFR) of the parasite Trypanosoma cruzi (T. cruzi) is a potential target for developing drugs to treat Chagas' disease. We have undertaken a detailed structure-activity study of this enzyme. We report here synthesis and characterization of six potent inhibitors of the parasitic enzyme. Inhibitory activity of each compound was determined against T. cruzi and human DHFR. One of these compounds, ethyl 4-(5-[(2,4-diamino-6-quinazolinyl)methyl]amino-2-methoxyphenoxy)butanoate (6b) was co-crystallized with the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of T. cruzi and the crystal structure of the ternary enzyme:cofactor:inhibitor complex was determined. Molecular docking was used to analyze the potential interactions of all inhibitors with T. cruzi DHFR and human DHFR. Inhibitory activities of these compounds are discussed in the light of enzyme-ligand interactions. Binding affinities of each inhibitor for the respective enzymes were calculated based on the experimental or docked binding mode. An estimated 60-70% of the total binding energy is contributed by the 2,4-diaminoquinazoline scaffold.
PubMed: 20452776
DOI: 10.1016/j.bmc.2010.04.020
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.5 Å)
構造検証レポート
Validation report summary of 3kjs
検証レポート(詳細版)ダウンロードをダウンロード

237735

件を2025-06-18に公開中

PDB statisticsPDBj update infoContact PDBjnumon